~~<i id='ED6866DE31'><strike id='ED6866DE31'><tt id='ED6866DE31'><pre id='ED6866DE31'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：Wikipedia 2025-09-07 21:55:35 - browse：8

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Biotech stock slump in 2023: awaiting the turnaround

focus

hotspot

focus

knowledge

Whopolicesalgorithms?HowwouldyounamethefirstapprovedCRISPRmedicine?Andwhatpairswellwithabiotechdownt

WSS

FDA's Woodcock to retire early next year

FDA panel to weigh approval of NurOwn, controversial ALS drug

Astellas still sees hope in its gene therapy after four deaths

Biotech lab space demand falls sharply

Why medical students are struggling with mental health

FDA's Woodcock to retire early next year

focus

focus

focus

Walensky prepares to leave CDC — and Congress — behind

Intarcia’s device

Supreme Court strikes down use of affirmative action

A daunting task: navigating dual Medicare, Medicaid eligibility

Moonlake's readout produced a cash windfall. Risks remain

In key trial, Verve's treatment lowers cholesterol levels in patients

How one medical school became remarkably diverse

Hospitals look to new technology to keep health care workers safe

FDA approval of Sarepta Duchenne genetic therapy gives me hope

NYU radiologists take on the challenge of expensive MRI machines

hotspot

Lasker Awards 2023: Winners in biomedical research

Drug for rare kidney disease narrowly misses mark in clinical trial

Why medical students are struggling with mental health

Weight loss drug costs may need more research, senator suggests

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Does good food count as health care? Study aims to find out

hotspot

focus

knowledge

knowledge